Roku, Inc. (ROKU)

CTI BioPharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	4,395	4,113	3,485	3,127	2,765	1,778
Revenue Growth (YoY)	17.32%	18.03%	11.45%	13.09%	55.45%	57.53%
Cost of Revenue	2,460	2,307	1,892	1,685	1,356	970.17
Gross Profit	1,935	1,806	1,593	1,441	1,409	808.22
Selling, General & Admin	1,333	1,273	1,261	1,165	711.9	472.69
Research & Development	726.94	720.28	767.98	769.32	461.6	355.78
Operating Expenses	2,060	1,993	2,029	1,934	1,174	828.47
Operating Income	-124.95	-187.17	-436.28	-492.75	235.1	-20.25
Interest Expense	-1.3	-0.41	-0.73	-5.16	-2.98	-3.43
Currency Exchange Gain (Loss)	-6.4	-6.4	-1.5	8.2	-1.2	1.3
Other Non Operating Income (Expenses)	95.65	103.61	90.83	36.1	5.67	3.93
EBT Excluding Unusual Items	-37.01	-90.37	-347.68	-453.61	236.59	-18.45
Merger & Restructuring Charges	-31	-31	-356.09	-38.14	-	-
Gain (Loss) on Sale of Investments	1.41	1.41	4.35	-0.53	-	-
Pretax Income	-66.6	-119.96	-699.43	-492.28	236.59	-18.45
Income Tax Expense	-5.09	9.43	10.13	5.72	-5.8	-0.95
Net Income	-61.51	-129.39	-709.56	-498.01	242.39	-17.51
Net Income to Common	-61.51	-129.39	-709.56	-498.01	242.39	-17.51
Shares Outstanding (Basic)	146	145	142	138	133	124
Shares Outstanding (Diluted)	146	145	142	138	142	124
Shares Change (YoY)	1.84%	2.16%	2.84%	-2.82%	14.27%	7.60%
EPS (Basic)	-0.42	-0.89	-5.01	-3.62	1.83	-0.14
EPS (Diluted)	-0.42	-0.89	-5.01	-3.62	1.71	-0.14
Free Cash Flow	389.85	212.98	173.24	-149.9	188.04	65.81
Free Cash Flow Per Share	2.67	1.47	1.22	-1.09	1.33	0.53
Gross Margin	44.04%	43.90%	45.71%	46.09%	50.95%	45.45%
Operating Margin	-2.84%	-4.55%	-12.52%	-15.76%	8.50%	-1.14%
Profit Margin	-1.40%	-3.15%	-20.36%	-15.93%	8.77%	-0.98%
Free Cash Flow Margin	8.87%	5.18%	4.97%	-4.79%	6.80%	3.70%
EBITDA	136.88	81.89	-157.98	-209.74	372.29	37.85
EBITDA Margin	3.11%	1.99%	-4.53%	-6.71%	13.47%	2.13%
D&A For EBITDA	261.83	269.05	278.3	283.01	137.19	58.1
EBIT	-124.95	-187.17	-436.28	-492.75	235.1	-20.25
EBIT Margin	-2.84%	-4.55%	-12.52%	-15.76%	8.50%	-1.14%
Revenue as Reported	4,395	4,113	3,485	3,127	2,765	1,778
Advertising Expenses	-	9.7	3.7	10	35.2	7.1

Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q